Sonnet to merge with crypto-backed firm, forming Hyperliquid Strategies with $888 million in assets, plus HYPE blockchain ...

Sonnet BioTherapeutics pivots to crypto with $888M deal, forming Hyperliquid Strategies Inc. to hold 12.6M HYPE tokens.

Sonnet BioTherapeutics to merge with Rorschach I LLC in a $888 million deal, forming crypto-focused Hyperliquid Strategies ...

The cryptocurrency space has seen a wave of momentum around Hyperliquid, as its native token HYPE continues to surge in value ...

Sonnet BioTherapeutics will transform into a new entity called HyperLiquid Strategies at the agreement's close. The new company is expected to hold 12.6 million HYPE tokens and gross cash invested of ...

Detailed price information for Sonnet Biotherapeutics Holdings Inc (SONN-Q) from The Globe and Mail including charting and trades.

Hyperliquid (HYPE) trades near $48 on Monday following Sonnet BioTherapeutics' (SONN) announcement that it has entered a ...

Sonnet BioTherapeutics is merging with Rorschach I LLC to form Hyperliquid Strategies in an $888M deal. The merger boosts HYPE token’s market momentum.

Combined company expected to become largest U.S.-based publicly listed company to hold HYPE in its treasuryPRINCETON, N.J., July 14, 2025 ( ...